Cargando…
Monocyte to High-Density Lipoprotein Ratio (MHR) as a predictor of mortality and Major Adverse Cardiovascular Events (MACE) among ST Elevation Myocardial Infarction (STEMI) patients undergoing primary percutaneous coronary intervention: a meta-analysis
BACKGROUND: Monocyte to High Density Lipoprotein Ratio (MHR) is a new marker that has been associated with major adverse cardiovascular outcomes among STEMI patients. We sought to strengthen the association between MHR and mortality and major adverse cardiovascular events (MACEs) among STEMI patient...
Autores principales: | Villanueva, Danielle Louis E., Tiongson, Marc Denver, Ramos, John Daniel, Llanes, Elmer Jasper |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098114/ https://www.ncbi.nlm.nih.gov/pubmed/32216795 http://dx.doi.org/10.1186/s12944-020-01242-6 |
Ejemplares similares
-
The blood monocyte to high density lipoprotein cholesterol ratio (MHR) is a possible marker of carotid artery plaque
por: Xi, Jie, et al.
Publicado: (2022) -
The Predictive Value of Monocyte/High-Density Lipoprotein Ratio (MHR) and Positive Symptom Scores for Aggression in Patients with Schizophrenia
por: Cheng, Ning, et al.
Publicado: (2023) -
Correction: The blood monocyte to high density lipoprotein cholesterol ratio (MHR) is a possible marker of carotid artery plaque
por: Xi, Jie, et al.
Publicado: (2022) -
Compared with the monocyte to high-density lipoprotein ratio (MHR) and the neutrophil to lymphocyte ratio (NLR), the neutrophil to high-density lipoprotein ratio (NHR) is more valuable for assessing the inflammatory process in Parkinson’s disease
por: Liu, Zhu, et al.
Publicado: (2021) -
Monocyte-to-high-density lipoprotein-cholesterol ratio (MHR) and the risk of all-cause and cardiovascular mortality: a nationwide cohort study in the United States
por: Jiang, Ming, et al.
Publicado: (2022)